# Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer

> **NCT06889467** · — · RECRUITING · sponsor: **Barzilai Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Non Small Cell Lung Cancer (NSCLC)
- Lung Cancer (NSCLC)
- Lung Cancer - Non Small Cell
- Pulmonary Nodule

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06889467
- **Lead sponsor:** Barzilai Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-20
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06889467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06889467, "Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06889467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*